High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodes

[摘要] The treatment of advanced nonsmall cell lung cancer (NSCLC) with PD-1/PD-L1 immune checkpoint inhibitors has improved clinical outcome for a proportion of patients. The current challenge is to find better biomarkers than PD-L1 immunohistochemistry (IHC) t

[学科分类] 呼吸医学